COVID-19 rapid test

for antigensnasalimmunofluorescence

Verify quickly that COVID-19 isn't spreading in your population with a rapid microfluidic assay that provides actionable, lab-comparable and cost-efficient results for pooled patient samples in just 5 minutes. Test benefits Quickly and easily scale up testing Save time: Pooled testing can result in a 40-60% reduction in testing Microfluidic immunofluorescence assay Easy to implement at point of care No refrigeration storage required: room temperature storage (2-30°C) Small and portable Instrument Minimal handling steps INQUIRE NOW Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run. Test performance In clinical studies, the LumiraDx SARS-CoV-2 Ag Ultra Pool test demonstrated 93.1%* positive agreement versus RT-PCR in samples collected up to and including 12 Days since onset of symptoms Verify quickly that COVID-19 isn’t spreading in your population The following table shows the performance for subsets grouped by Ct value, of the results above, illustrating that the LumiraDx SARS-CoV-2 Ag Ultra Pool test has high sensitivity in patients with a Ct value <34. Samples with Cts above 33-34 are generally considered to be non-infectious1 indicating that the LumiraDx SARS-CoV-2 Ag Ultra Pool test can verify quickly that COVID-19 isn’t spreading in your population.